Quantcast

Latest Stem cells Stories

2014-06-05 12:31:31

FARMINGTON, Conn., June 5, 2014 /PRNewswire/ -- ImStem Biotechnology, Inc. (ImStem) announced today it has successfully treated an animal model of multiple sclerosis (MS) using human embryonic stem cells (hESC) derived mesenchymal stem cells (MSCs), called hES-MSCs. Photo - http://photos.prnewswire.com/prnh/20140605/94816Photo - http://photos.prnewswire.com/prnh/20140605/94808 MS is a chronic neuroinflammatory disease with no cure. Most current MS therapies offer only palliative...

Scientists Successfully Transplant And Grow Stem Cells In Pigs
2014-06-05 03:38:48

Nathan Hurst, University of Missouri One of the biggest challenges for medical researchers studying the effectiveness of stem cell therapies is that transplants or grafts of cells are often rejected by the hosts. This rejection can render experiments useless, making research into potentially life-saving treatments a long and difficult process. Now, researchers at the University of Missouri have shown that a new line of genetically modified pigs will host transplanted cells without the...

2014-06-05 08:28:12

EYSINS, Switzerland, June 5, 2014 /PRNewswire/ -- In line with its mission of market innovator, Biosafe is proud to announce the launch of the SepaMax multiprocessing device, on the occasion of the International Cord Blood Symposium in San Francisco. (Logo: http://photos.prnewswire.com/prnh/20140407/679480 ) SepaMax is designed for high throughput cell processing. Based on Biosafe's industry-leading Sepax technology, it offers six processing modules in a...

2014-06-04 23:07:48

OTTR Chronic Care Solutions Inc. ™ has successfully supported its first customer, Barnes-Jewish Hospital of Washington University School of Medicine in St. Louis, Missouri, in the submission, and retrieval, of transplant data using the AGNIS application and framework in a production environment. Omaha, NE (PRWEB) June 04, 2014 OTTR Chronic Care Solutions Inc. ™ has successfully supported its first customer, Barnes-Jewish Hospital of Washington University School of Medicine in St....

2014-06-04 23:06:47

Insception Lifebank, Canada's largest cord blood program, now offers expecting parents the option to bank a section of the actual umbilical cord tissue, in addition to banking cord blood. Toronto, Canada (PRWEB) June 04, 2014 Insception Lifebank, Canada's largest cord blood program, now offers expecting parents the option to bank a section of the actual umbilical cord tissue, in addition to banking cord blood. "With exciting developments in stem cell research, scientists...

2014-06-04 12:29:10

Surveyed U.S. Payers Will Accept High Yearly Costs for Effective Novel Treatments, According to Findings from Decision Resources Group BURLINGTON, Mass., June 4, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. retinal specialists are highly willing to prescribe key emerging therapies for the treatment of geographic atrophy (GA), the dry form of advanced age-related macular degeneration (AMD). In particular, clinicians expect to prescribe Roche/Genentech's lampalizumab...

2014-06-03 23:02:06

On June 3, at the 7th Annual Massachusetts Life Sciences Innovation Day, Dr. James L. Sherley, Director of The Adult Stem Cell Technology Center, LLC presented a new technology developed to identify drug candidates that are toxic to adult stem cells. This first technology of its kind meets a long-standing unmet need of the pharmaceutical industry, with potential to save billions of dollars in drug development costs each year while accelerating the arrival of new effective, and safe, drugs...

2014-06-03 12:38:22

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biobanking for Medicine: Technology, Industry and Market 2014-2024http://www.reportbuyer.com/pharma_healthcare/biotechnology/biobanking_medicine_technology_market.html Report DetailsBiobanks - how to find business trends, R&D, and revenue forecastsWhat does the future hold for medical biobanks? Now you get technological and commercial predictions from 2014. Stay ahead, then, for data,...

2014-06-03 12:37:18

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Translational Regenerative Medicine: Market Prospects 2014-2024http://www.reportbuyer.com/pharma_healthcare/research_r_d/translational_regenerative_medicine_market_prospects_2012_2022.html Report DetailsOur new study shows you the commercial potential of regenerative treatmentsWhat does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to...

2014-06-03 11:48:40

University of Colorado Denver At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discovered by OncoMed Pharmaceuticals targeting cancer stem cells (CSCs). The drug was generally well tolerated, and several of the 26 patients with advanced solid tumors experienced stable disease for greater than six months. Three trials...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related